CTI BioPharma Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	12,925	12,605	16,757	16,591	14,017	12,330	Upgrade
Market Cap Growth	-28.94%	-24.77%	1.00%	18.36%	13.69%	14.17%	Upgrade
Enterprise Value	12,646	12,110	16,025	14,614	16,403	20,927	Upgrade
Last Close Price	19.12	5.63	7.31	6.93	9.03	7.69	Upgrade
PE Ratio	92.02	62.64	149.34	59.80	12.34	134.54	Upgrade
Forward PE	29.81	18.20	23.12	15.88	12.48	22.57	Upgrade
PB Ratio	1.43	1.28	1.67	1.55	1.18	1.18	Upgrade
P/TBV Ratio	1.43	1.28	1.67	1.55	1.91	1.92	Upgrade
P/FCF Ratio	17.68	16.18	390.79	35.11	64.41	124.00	Upgrade
P/OCF Ratio	17.67	16.16	384.14	35.04	64.15	123.18	Upgrade
PEG Ratio	-	0.77	0.77	0.77	0.77	0.77	Upgrade
EV/EBITDA Ratio	234.20	-	-	-	-	-	Upgrade
EV/EBIT Ratio	237.11	-	-	-	-	-	Upgrade
EV/FCF Ratio	17.30	15.54	373.72	30.92	75.37	210.46	Upgrade
Quick Ratio	5.38	7.36	2.39	6.77	8.97	2.63	Upgrade
Current Ratio	5.50	7.40	2.40	6.79	8.98	2.64	Upgrade
Return on Equity (ROE)	1.54%	2.03%	1.08%	3.49%	16.26%	1.63%	Upgrade
Return on Assets (ROA)	-0.43%	-0.39%	-0.35%	-0.38%	-0.35%	-0.17%	Upgrade
Return on Capital (ROIC)	-0.45%	-0.41%	-0.37%	-0.39%	-0.37%	-0.19%	Upgrade
Earnings Yield	1.14%	1.60%	0.67%	1.67%	8.11%	0.74%	Upgrade
FCF Yield	5.66%	6.18%	0.26%	2.85%	1.55%	0.81%	Upgrade
Dividend Yield	5.71%	-	15.19%	24.05%	15.38%	14.46%	Upgrade
Payout Ratio	261.23%	374.82%	338.83%	610.88%	39.45%	613.78%	Upgrade
Buyback Yield / Dilution	-4.29%	-	-12.34%	-49.31%	-	-	Upgrade
Total Shareholder Return	1.43%	-	2.85%	-25.26%	15.38%	14.46%	Upgrade

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.